Want to see FR:ALTME full AI Analyst Report?
TME Pharma N.V. (ALTME) Income Statement
TME Pharma N.V. Income Statement
Last quarter (Q4 2025), TME Pharma N.V.'s total revenue was $-27.00K, a decrease of 258.82% from the same quarter last year. In Q4, TME Pharma N.V.'s net income was $-1.18M. See TME Pharma N.V.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 19.00K | $ 17.00K | $ 0.00 | $ 33.00K | |
| $ -8.00K | $ -78.00K | $ -127.00K | $ -92.00K | $ -65.97K | |
| $ 2.90M | $ 5.20M | $ 5.50M | $ 12.00M | $ 13.45M | |
| Depreciation and Amortization | $ 8.00K | $ 78.00K | $ 144.00K | $ 92.00K | $ 66.00K |
| $ -2.90M | $ -5.17M | $ -5.07M | $ -11.63M | $ -12.88M | |
| $ -2.91M | $ -5.28M | $ -5.62M | $ -12.03M | $ -13.27M | |
| $ -377.00K | $ -445.00K | $ -1.11M | $ -3.10M | $ -1.19M | |
| $ -3.29M | $ -5.72M | $ -6.73M | $ -15.13M | $ -14.45M | |
| $ -3.29M | $ -5.72M | $ -6.74M | $ -15.13M | $ -14.45M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.03 | $ -0.21 | $ -1.34 | $ -12.86 | $ -21.90 |
| Diluted EPS | $ -0.03 | $ -0.21 | $ -1.34 | $ -12.86 | $ -21.90 |
| Weighted Average Shares Outstanding | 94.15M | 27.35M | 5.02M | 1.18M | 659.00K |
| Weighted Average Shares Outstanding (Diluted) | 94.15M | 27.35M | 5.02M | 1.18M | 659.85K |
Currency in EUR